Abstract
Since December 2019, coronavirus disease 2019 (COVID-19) has been an international public health emergency. The possibility of COVID-19 should be considered primarily in patients with new-onset fever or respiratory tract symptoms. However, these symptoms can occur with other viral respiratory illnesses. We reported a case of severe acute respiratory syndrome coronavirus 2 and influenza A virus coinfection. During the epidemic, the possibility of COVID-19 should be considered regardless of positive findings for other pathogens.
Keywords:
infectious diseases; respiratory medicine.
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
MeSH terms
-
Amides / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / isolation & purification*
-
COVID-19
-
Coinfection
-
Coronavirus Infections / complications*
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / drug therapy
-
Diagnosis, Differential
-
Glucocorticoids / therapeutic use
-
Humans
-
Influenza A virus / isolation & purification*
-
Influenza, Human / complications*
-
Influenza, Human / diagnosis*
-
Influenza, Human / economics
-
Lung / diagnostic imaging
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / complications*
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / drug therapy
-
Pregnenediones / therapeutic use
-
Pyrazines / therapeutic use
-
Radiography
-
Real-Time Polymerase Chain Reaction
-
SARS-CoV-2
Substances
-
Amides
-
Anti-Bacterial Agents
-
Antiviral Agents
-
Glucocorticoids
-
Pregnenediones
-
Pyrazines
-
favipiravir
-
ciclesonide